Enclosed herewith unaudited financial result for the quarter ended June 30, 2026

July 31, 2026 BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers Dalal Street, Fort, Mumbai- 400 001 Scrip Code: 516110 Sub.: Outcome of Board Meeting of Family Care Hospitals Limited held on Friday, July 31, 2026 Dear Sir/Madam, The Board of Directors at its Meeting held on Friday, July 31, 2026 considered and after due deliberation, inter alia; 1. The Standalone Unaudited Financial Results for the first quarter ended June 30, 2026 along with the Limited Review Repot. 2. The appointment of Mr. Ashdullah Kahn as the Company Secretary & Compliance Officer of the Company effective immediately (Refer to Annexure A for the relevant details regarding her appointment.) In respect of the above, we hereby enclose the following: i. The Un-Audited Standalone Financial results for the Quarter ended 30 June 2026, in the format specified under Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and ii. Limited Review Report issued by the statutory Auditors of the Company on the Un-Audited Standalone Financial results for the Quarter ended 30 June 2026 The meeting commenced at 2:30 PM and concluded at 6:00 PM. We request you to take this information on Records. For Family Care Hospitals Limited Suchit Raghunath Modshing Whole-Time Director Din No. 10974977 ANNEXURE-I The required details as per SEBI Circular no. SEBI/HO/CFD/CFD-PoD 1/P/CIR/2023/123 dated July 13, 2023 is as follows: [Change in Directors, Key Managerial Personnel (Managing Director, Chief Executive Officer, Chief Financial Officer, Company Secretary etc.), Auditor and Compliance Officer] Sr. Disclosure Requirement Details 1. Reason for change via Appointment, Resignation, Appointment of Mr. Ashdullah Cessation, Removal, Death or otherwise Khan as a Company Secretary & Compliance Officer of the company with immediate effect 2. Date of Appointment / Cessation (as applicable) July 31, 2026 3. Brief profile (in case of appointment) Mr. Ashdullah Khan is an Associate Member of the Institute of Company Secretaries of India and has experience in dealing with matters of Companies Act, Listing Regulations and allied laws. 4. Disclosure of relationships between directors Not Applicable (in case of appointment of a director) LIMITED REVIEW REPORT FOR QUARTERLY ENDED 30th June, 2026 The Board of Directors, Family Care Hospitals Limited. (Formerly known as Scandent Imaging Limited) Plot No. 357, Road No. 26, Wagle Industrial Estate, MIDC, Thane (West) – 400604 Re: Report on financial Results for the Quarterly ended 30th June, 2026 1. We have reviewed the accompanying statement of unaudited financial results of FAMILY CARE HOSPITALS LIMITED ('the company') for the Quarterly ended 30th June, 2026 ('the Statement') attached herewith, being submitted by the company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. This statement is the responsibility of the Company's management and has been approved by the Board of Directors. Our responsibility is to issue a report on these financial statements based on our review. 3. We conducted our review in accordance with Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data, and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 4. Attention is invited to the following: We draw attention to Note No. 5 of the financial results regarding Discount Coupon Vouchers amounting to ₹38.03 crore included under the head of Inventories. As disclosed by the management, these vouchers have remained unutilised due to the closure of the Company’s main hospital operations. Although the company intends to debit/transfer this stock to the related party, the necessary shareholder approval for the same has not been received up to June 30, 2026. Consequently, pending such approval and the revival of operations, the inventory continues to be carried at its book value. In view of the pending regulatory/shareholder approvals, the prolonged closure of operations, and the absence of a definitive timeframe for revival, we are unable to comment upon the realizable value of these vouchers, the appropriateness of carrying them at book value, and the consequential financial impact on the results as at June 30, 2026. 5. Based on our review conducted as above, except for the matters to which attention is drawn above, nothing has come to our attention that causes us to believe that the accompanying Statement of Unaudited Financial Results, prepared in accordance with the applicable Indian Accounting Standards specified under Section 133 of the Companies Act,2013, read with Rule 7 of the Companies (Accounts) Rules,2014 and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including the manner in which it is to be disclosed, or that it contains any material misstatement. Yours faithfully, Rafik and Associates Chartered Accountants ICAI FRN 146573W Rafik Sejam Sheikh Properietor Membership No: 182278 Date: 31st July, 2026 Place: Mumbai Udin:- 26182278ROWIHL1856 FAMILY CARE HOSPITALS LIMITED CIN : L93000MH1994PLC080842 Statement of Audited Financial Results for the Quarter and Year Ended June 30, 2026 [Figures in ₹ lakhs unless stated otherwise] Quarter Ended Year Ended Particulars 30.06.2026 31.03.2026 30.06.2025 31.03.2026 Unaudited Audited Unaudited Audited 1 Revenue from Operations 5.00 5.86 1.72 20.97 2 Other Income 1.13 10.82 0.00 24.04 3 Total Income (1 + 2) 6.13 16.68 1.72 45.02 4 Expenses Purchase of Stock-In-Trade 4.02 4.69 0.00 10.18 Changes in inventories of finished goods, work-in-progress 0.00 0.00 0.00 0.00 and stock-in-trade Employee Benefits Expense 9.72 14.46 10.77 49.17 Finance Costs 6.44 11.77 7.52 37.32 Depreciation and Amortisation Expense 19.94 20.22 23.13 88.19 Other Expenses 8.38 (234.10) 29.82 286.48 Prior Period Expenses 0.00 14.22 14.22 Total Expenses (4) 48.50 (168.74) 71.24 485.57 5 Profit / (Loss) before exceptional items and tax (3 - 4) (42.37) 185.42 (69.52) (440.55) 6 Exceptional items (427.73) 0.00 (427.73) 7 Profit / (Loss) before tax (5 + 6) (42.37) (242.31) (69.52) (868.29) 8 Tax Expense (a) Current Tax 0.00 0.00 0.00 0.00 (b) Deferred Tax Credit / (Charge) 0.00 0.00 0.00 0.00 (c) Earlier Year 0.00 0.00 0.00 0.00 9 Profit / (Loss) for the year (7 - 8) (42.37) (242.31) (69.51) (868.29) 10 Other Comprehensive income (a) (i) Items that will not be reclassified to Profit or Loss Re-measurement of defined benefit plans 0.00 0.83 0.00 0.83 (ii) Income tax relating to items that will not be 0.00 0.00 0.00 0.00 reclassified to profit or loss (b) (i) Items that will be reclassified to Profit or Loss 0.00 0.00 0.00 0.00 (ii) Income tax relating to items that will be reclassified to 0.00 0.00 0.00 0.00 profit or loss Other Comprehensive income for the year (10) 0.00 0.83 0.00 0.83 11 Total Comprehensive income for the year (9 + 10) (42.37) (241.48) (69.51) (867.46) Paid-up equity share capital (Face Value - ₹ 10 per 12 5,401.48 5,401.48 5,401.48 5,401.48 share) Earnings Per Share (of ₹ 10/- each) (not annualised): 13 (0.08) (0.45) (0.39) (1.61) Basic earnings per share ₹ Earnings Per Share (of ₹ 10/- each) (not annualised): 14 (0.08) (0.45) (0.39) (1.61) Diluted earnings per share ₹ Notes: 1 The Statement of financial results have been prepared in accordance [Showing first 8,000 characters — download PDF for full document]